{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T23:42:13Z","timestamp":1782949333200,"version":"3.54.5"},"reference-count":24,"publisher":"BMJ","issue":"2","license":[{"start":{"date-parts":[[2023,12,26]],"date-time":"2023-12-26T00:00:00Z","timestamp":1703548800000},"content-version":"unspecified","delay-in-days":25,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100016309","name":"Bayer, United Kingdom","doi-asserted-by":"publisher","award":["\u00a38000"],"award-info":[{"award-number":["\u00a38000"]}],"id":[{"id":"10.13039\/100016309","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Open Heart"],"accepted":{"date-parts":[[2023,11,10]]},"published-print":{"date-parts":[[2023,12]]},"abstract":"<jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>There have been relatively few studies detailing the real-world effectiveness and safety of accelerated diagnostic protocols (ADP), using high sensitivity cardiac troponin (hs-cTn).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>To analyse the safety and effectiveness of early emergency department (ED) discharge following implementation of the European Society of Cardiology (ESC) 0\/3-hour ADP for suspected acute coronary syndromes (ACS).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Method<\/jats:title>\n                  <jats:p>We prospectively studied 2 cohorts of consecutive suspected ACS presentations to ED before (n=1642) and after (n=1376, 2 centres) implementation of the ESC 0\/3-hour ADP incorporating limit of detection rule out. Safety was defined by MACE (major adverse cardiac events) inclusive of type 1 myocardial infarction (MI) in patients discharged from ED, and clinical effectiveness by percentage ED discharge. Continuous variables and categorical data were evaluated by independent t-test and \u03c7<jats:sup>2<\/jats:sup> test, respectively. Time-to-event data were analysed as survival data and converted to Kaplan-Meier curves for interpretation.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>In the preimplementation period, there was a higher prevalence of MI. Discharge from ED increased by &gt;100% (from 27.1% to 56.5% of the cohort) with no safety signal (MACE rate 4\/444 (0.9%) vs 4\/769 (0.52%), p=0.430 for the 2011 and 2018 cohort, respectively). This correlated with a marked reduction in length of stay overall but a more modest reduction for those discharged from ED (6 hours 10 min vs 5 hours 25 min, p&lt;0.001) for the 2011 and 2018 cohort, respectively. There were improvements in presentation to blood draw (163\u201390\u2009min, p&lt;0.001). Time from presentation to first ECG actually increased (16.2 vs 31.2\u2009min, p&lt;0.001). Analysis of hs-cTn values and ECGs revealed a maximum ED discharge rate of 69%, by applying the 0\/3-hour protocol, implying potential for increasing safe ED discharge.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Implementation of an ADP with hs-cTn is safe and effective for early rule-out and discharge of suspected ACS but require considerable resources and education to optimise maximal patient flow.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/openhrt-2023-002366","type":"journal-article","created":{"date-parts":[[2023,12,27]],"date-time":"2023-12-27T00:50:11Z","timestamp":1703638211000},"page":"e002366","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":3,"title":["Implementation of the European Society of Cardiology 0\/3-hour accelerated diagnostic protocol, using high sensitive troponin T: a clinical practice evaluation of safety and effectiveness involving 3003 patients with suspected acute coronary syndrome"],"prefix":"10.1136","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-3262-434X","authenticated-orcid":false,"given":"James Daniel","family":"Hatherley","sequence":"first","affiliation":[{"name":"Liverpool Centre for Cardiovascular Sciences, University of Liverpool, Liverpool, UK"},{"name":"Department of Cardiology, Royal Liverpool and Broadgreen Hospitals NHS Trust, Liverpool, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Salmon","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Aintree University Hospitals NHS Foundation Trust, Liverpool, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7000-5996","authenticated-orcid":false,"given":"Paul O","family":"Collinson","sequence":"additional","affiliation":[{"name":"Clinical Blood Sciences, St George's University Hospitals NHS Foundation Trust, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleem","family":"Khand","sequence":"additional","affiliation":[{"name":"Liverpool Centre for Cardiovascular Sciences, University of Liverpool, Liverpool, UK"},{"name":"Department of Cardiology, Aintree University Hospitals NHS Foundation Trust, Liverpool, UK"},{"name":"Department of Cardiology, Liverpool Heart and Chest NHS Foundation Trust, Liverpool, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2023,12,26]]},"reference":[{"key":"2025081612185869000_10.2.e002366.1","doi-asserted-by":"publisher","DOI":"10.1001\/archinternmed.2012.3698"},{"key":"2025081612185869000_10.2.e002366.2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.118.034260"},{"key":"2025081612185869000_10.2.e002366.3","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1093\/clinchem\/hvaa280","article-title":"Optimizing the use of high-sensitivity troponin assays for the early rule-out of myocardial infarction in patients presenting with chest pain: A systematic review","volume":"67","author":"Westwood","year":"2021","journal-title":"Clin Chem"},{"key":"2025081612185869000_10.2.e002366.4","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2021-001769","article-title":"Implementation of an early rule-out pathway for myocardial infarction using a high-sensitivity cardiac troponin T assay","volume":"8","author":"Sandeman","year":"2021","journal-title":"Open Heart"},{"key":"2025081612185869000_10.2.e002366.5","doi-asserted-by":"publisher","DOI":"10.7326\/M16-2562"},{"key":"2025081612185869000_10.2.e002366.6","first-page":"421","article-title":"A direct comparison of decision rules for early discharge of suspected acute coronary syndromes in the era of high sensitivity troponin","volume":"8","author":"Chew","year":"2019","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"2025081612185869000_10.2.e002366.7","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehv320"},{"key":"2025081612185869000_10.2.e002366.8","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2011.04.007"},{"key":"2025081612185869000_10.2.e002366.9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2012.08.001"},{"key":"2025081612185869000_10.2.e002366.10","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehs154"},{"key":"2025081612185869000_10.2.e002366.11","first-page":"577","article-title":"What to do when you question cardiac troponin values","volume":"7","author":"Mair","year":"2018","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"2025081612185869000_10.2.e002366.12","doi-asserted-by":"publisher","DOI":"10.1373\/clinchem.2009.134460"},{"key":"2025081612185869000_10.2.e002366.13","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2011.1896"},{"key":"2025081612185869000_10.2.e002366.14","doi-asserted-by":"publisher","DOI":"10.1373\/clinchem.2018.298638"},{"key":"2025081612185869000_10.2.e002366.15","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1093\/clinchem\/hvab066","article-title":"How well do Laboratories adhere to recommended guidelines for cardiac biomarkers management in Europe? the cardiac marker guideline uptake in Europe (CAMARGUE) study of the European Federation of laboratory medicine task group on cardiac markers","volume":"67","author":"Collinson","year":"2021","journal-title":"Clin Chem"},{"key":"2025081612185869000_10.2.e002366.16","unstructured":"Gov.UK (Website); UK government Website; accelerated access review. n.d. Available: https:\/\/www.gov.uk\/government\/publications\/accelerated-access-review-final-report"},{"key":"2025081612185869000_10.2.e002366.17","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.116.025021"},{"key":"2025081612185869000_10.2.e002366.18","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.116.025661"},{"key":"2025081612185869000_10.2.e002366.19","doi-asserted-by":"crossref","unstructured":"Thygesen K , Alpert JS , Jaffe AS , et al . n.d. Third universal definition of myocardial infarction. Gh;7:275. doi:10.1016\/j.gheart.2012.08.001","DOI":"10.1016\/j.gheart.2012.08.001"},{"key":"2025081612185869000_10.2.e002366.20","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.120.052380"},{"key":"2025081612185869000_10.2.e002366.21","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehaa624"},{"key":"2025081612185869000_10.2.e002366.22","doi-asserted-by":"crossref","first-page":"3720","DOI":"10.1093\/eurheartj\/ehad191","article-title":"ESC guidelines for the management of acute coronary syndromes: developed by the task force on the management of acute coronary syndromes of the European society of cardiology (ESC)","volume":"44","author":"Byrne","year":"2023","journal-title":"Eur Heart J"},{"key":"2025081612185869000_10.2.e002366.23","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2019.05.046"},{"key":"2025081612185869000_10.2.e002366.24","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.119.042891"}],"container-title":["Open Heart"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/openhrt-2023-002366","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,16]],"date-time":"2025-08-16T19:19:08Z","timestamp":1755371948000},"score":1,"resource":{"primary":{"URL":"https:\/\/openheart.bmj.com\/lookup\/doi\/10.1136\/openhrt-2023-002366"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":24,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2023,12,26]]},"published-print":{"date-parts":[[2023,12]]}},"alternative-id":["10.1136\/openhrt-2023-002366"],"URL":"https:\/\/doi.org\/10.1136\/openhrt-2023-002366","relation":{},"ISSN":["2053-3624"],"issn-type":[{"value":"2053-3624","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12]]}}}